These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8362885)

  • 41. Combating employee benefit cost and control issues: the case for coalition purchasing.
    Anastasio LN
    Benefits Q; 2005; 21(1):15-8. PubMed ID: 15825632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Integrating primary care and specialty pharmacy practice to improve ambulatory patient care services.
    Schuna AA
    Pharm Pract Manag Q; 1996 Jan; 15(4):1-7. PubMed ID: 10172544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacoeconomics and the formulary decision-making process.
    Bakst A
    Hosp Formul; 1995 Jan; 30(1):42-50. PubMed ID: 10172201
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of local competition on the willingness of community pharmacies to supply medication therapy management services.
    Brooks JM; Klepser DG; Urmie JM; Farris KB; Doucette WR
    J Health Hum Serv Adm; 2007; 30(1):4-27. PubMed ID: 17557694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Moving toward the provision of comprehensive ambulatory-care pharmaceutical services.
    Abramowitz PW; Mansur JM
    Am J Hosp Pharm; 1987 May; 44(5):1155-63. PubMed ID: 3605126
    [No Abstract]   [Full Text] [Related]  

  • 46. The 1982 Hoechst Lecture: "Cost effectiveness--the emerging 'bottom line' for pharmacy?!".
    Marshman JA
    Can J Hosp Pharm; 1982; 35(2):39-41. PubMed ID: 10309676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coalition seeks changes in drug price law.
    Wagner L
    Mod Healthc; 1992 Jul; 22(30):16. PubMed ID: 10119572
    [No Abstract]   [Full Text] [Related]  

  • 48. ASHP statement on third-party compensation for clinical services by pharmacists.
    Am J Hosp Pharm; 1985 Jul; 42(7):1580-1. PubMed ID: 4025361
    [No Abstract]   [Full Text] [Related]  

  • 49. ASHP guidelines for implementing and obtaining compensation for clinical services by pharmacists.
    Am J Hosp Pharm; 1985 Jul; 42(7):1581-2. PubMed ID: 4025362
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmacoeconomic series: Part I. Pharmacoeconomics and the evaluation of drugs and services.
    McGhan WF
    Hosp Formul; 1993 Apr; 28(4):365-6, 371-3, 377-8. PubMed ID: 10125323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmaceutical services to improve drug therapy for home health care patients.
    Solomon DK; Baumgartner RP; Weissman AM; Briscoe ME; Smith RM; McCormick WC
    Am J Hosp Pharm; 1978 May; 35(5):553-7. PubMed ID: 655176
    [No Abstract]   [Full Text] [Related]  

  • 52. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacoeconomic factors in the treatment of acute hypertension.
    Shulkin DJ
    Hosp Formul; 1994 Aug; 29 Suppl 2():S15-20. PubMed ID: 10135742
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tender mercies: increasing access to hospice services for children with life-threatening conditions.
    Dabbs D; Butterworth L; Hall E
    MCN Am J Matern Child Nurs; 2007; 32(5):311-9. PubMed ID: 17728594
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Using clinical evidence to manage pharmacy benefits: experiences of six states.
    Bergman D; Hoadley J; Kaye N; Crowley J; Hostetter M
    Issue Brief (Commonw Fund); 2006 Mar; (899):1-14. PubMed ID: 16562357
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The triad of crises in health care.
    Simmons HE
    Caring; 1992 Mar; 11(3):14-8. PubMed ID: 10117078
    [No Abstract]   [Full Text] [Related]  

  • 57. Patient care contributions of clinical pharmacists in four ambulatory care clinics.
    Hatoum HT; Witte KW; Hutchinson RA
    Hosp Pharm; 1992 Mar; 27(3):203-6, 208-9. PubMed ID: 10116720
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 59. State regulation of private health insurance: prescription drug benefits, experimental treatments, and consumer protection.
    Bolin JN; Buchanan RJ; Smith SR
    Am J Manag Care; 2002 Nov; 8(11):977-85. PubMed ID: 12437312
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ASHP guidelines on pharmaceutical services for ambulatory patients.
    Am J Hosp Pharm; 1991 Feb; 48(2):311-5. PubMed ID: 2003507
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.